Literature DB >> 11127102

Mass screening for human papillomavirus type 16 infection in infertile couples.

H Tanaka1, A Karube, H Kodama, J Fukuda, T Tanaka.   

Abstract

OBJECTIVE: To investigate the prevalence of human papillomavirus (HPV) type 16 infection among in vitro fertilization (IVF) couples and to identify clinical conditions related to HPV infection. STUDY
DESIGN: The presence of HPV type 16 DNA in the uterine cervix of 192 women who underwent IVF and in 99 semen samples collected from their husbands were determined by the nested polymerase chain reaction method.
RESULTS: Ten women (5.5%) and 4 men (4.0%) were found to be HPV type 16 DNA positive. However, presence of the HPV type 16 DNA in the cervix or semen did not have any impact on IVF treatment variables, including presence of tubal factor, incidence of pregnancies and abortions, and semen quality. Only one of four women, whose partner's semen was HPV type 16 DNA positive, had a DNA positive cervix.
CONCLUSION: These data provide useful information for counseling infertile couples with HPV type 16 infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11127102

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  12 in total

1.  Human papilloma virus DNA exposure and embryo survival is stage-specific.

Authors:  Andrew A Henneberg; William C Patton; John D Jacobson; Philip J Chan
Journal:  J Assist Reprod Genet       Date:  2006-07-27       Impact factor: 3.412

2.  Association Between Maternal Human Papillomavirus Infection and Adverse Pregnancy Outcomes: Systematic Review and Meta-Analysis.

Authors:  Joseph Niyibizi; Nadège Zanré; Marie-Hélène Mayrand; Helen Trottier
Journal:  J Infect Dis       Date:  2020-06-11       Impact factor: 5.226

3.  The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study.

Authors:  Anna R Giuliano; Carrie M Nielson; Roberto Flores; Eileen F Dunne; Martha Abrahamsen; Mary R Papenfuss; Lauri E Markowitz; Danelle Smith; Robin B Harris
Journal:  J Infect Dis       Date:  2007-09-17       Impact factor: 5.226

Review 4.  Human papillomavirus infection and fertility alteration: a systematic review.

Authors:  Tiatou Souho; Mohamed Benlemlih; Bahia Bennani
Journal:  PLoS One       Date:  2015-05-18       Impact factor: 3.240

Review 5.  Human papillomavirus in semen and the risk for male infertility: a systematic review and meta-analysis.

Authors:  Zhangyan Lyu; Xiaoshuang Feng; Ni Li; Wei Zhao; Luopei Wei; Yuheng Chen; Wenjing Yang; Hongxia Ma; Bing Yao; Kai Zhang; Zhibin Hu; Hongbing Shen; Dong Hang; Min Dai
Journal:  BMC Infect Dis       Date:  2017-11-09       Impact factor: 3.090

6.  The risk of human papillomavirus infection for male fertility abnormality: a meta-analysis.

Authors:  Yi-Quan Xiong; Yan-Xia Chen; Ming-Ji Cheng; Wen-Qiao He; Qing Chen
Journal:  Asian J Androl       Date:  2018 Sep-Oct       Impact factor: 3.285

7.  Sexually transmitted infections and sexual function in relation to male fertility.

Authors:  Claire Brookings; David Goldmeier; Hossein Sadeghi-Nejad
Journal:  Korean J Urol       Date:  2013-03-15

Review 8.  Human Papillomavirus Infection, Infertility, and Assisted Reproductive Outcomes.

Authors:  Nigel Pereira; Katherine M Kucharczyk; Jaclyn L Estes; Rachel S Gerber; Jovana P Lekovich; Rony T Elias; Steven D Spandorfer
Journal:  J Pathog       Date:  2015-11-01

9.  High HPV infection prevalence in men from infertile couples and lack of relationship between seminal HPV infection and sperm quality.

Authors:  Barbara Golob; Mario Poljak; Ivan Verdenik; Mojca Kolbezen Simoniti; Eda Vrtačnik Bokal; Branko Zorn
Journal:  Biomed Res Int       Date:  2014-04-06       Impact factor: 3.411

Review 10.  Human Papilloma Virus (HPV) and Fertilization: A Mini Review.

Authors:  Konstantinos Zacharis; Christina I Messini; George Anifandis; George Koukoulis; Maria Satra; Alexandros Daponte
Journal:  Medicina (Kaunas)       Date:  2018-07-27       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.